13F-HR filed by Foresite Capital Management VI LLC
Foresite Capital Management VI LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-12, with 20 holding rows worth $177,883,819.
- Accession
- 0001104659-25-076821
- Filer
- CIK 2013341
- Filed
- 2025-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 20 entries on the cover page, a total value of $177,883,819 stated on the cover page (in dollars after the unit check, H1), rows summing to $177,883,819 with VALUE read as dollars as filed, 13F file number 028-25267. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 2,221,474 | $57,758,324 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,253,379 | $16,469,400 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 244,900 | $13,067,864 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 4,247,670 | $12,743,010 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 1,562,500 | $12,500,000 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 949,260 | $8,818,625 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 585,000 | $7,669,350 | dollars as filed | |
| HINGE HEALTH INC A | 433313103 | COMMON STOCK | 135,000 | $6,986,250 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 1,731,233 | $6,924,932 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 146,332 | $6,385,928 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,276,520 | $5,297,558 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 160,000 | $5,008,000 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 594,025 | $4,473,008 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 210,000 | $4,355,400 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 2,875,357 | $3,249,153 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 144,468 | $3,036,717 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 40,000 | $1,136,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 70,000 | $1,047,900 | dollars as filed | |
| CASI PHARMACEUTICALS INC COM NEW | G1933S101 | Stock | 787,121 | $928,803 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,974 | $27,597 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-25-076821 | this filing | 2025-08-12 | acceptance time not in the bulk data set |